Veracyte, Inc.
VCYT
$31.47
$1.043.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -66.26% | 164.30% | 407.62% | 93.41% | 4.47% |
| Total Depreciation and Amortization | 6.38% | 2.44% | 2.65% | -11.77% | -13.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.42% | -26.66% | 21.31% | -71.90% | -5.09% |
| Change in Net Operating Assets | -4,515.38% | -101.57% | 125.42% | -1,699.93% | 192.06% |
| Cash from Operations | -18.15% | 1.31% | 429.86% | -157.65% | 9.75% |
| Capital Expenditure | -84.70% | 19.06% | -29.80% | 14.54% | 10.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,314.85% | 19.06% | -196.25% | 215.26% | 10.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.82% | 865.09% | -56.47% | 67.49% | -30.67% |
| Repurchase of Common Stock | -50.18% | -67.31% | 66.00% | -240.02% | 53.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -143.83% | 93,636.36% | 98.73% | -233.95% | 486.36% |
| Foreign Exchange rate Adjustments | -374.66% | 339.34% | 43.52% | -136.36% | 267.80% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.49% | 42.73% | 478.65% | -150.44% | 23.85% |
